Short answer
MeiraGTx Holdings plc (MGTX) filed its Q2 2026 10-Q quarterly report on Aug 13, 2026 for the quarter ended Jun 30, 2026. Quarterly revenue was $321M (up 5622.5% year over year) with net income of $161M.
Q2 2026 key financials · XBRL
- Revenue
- $321M
- +5622.5% YoY · +109604.4% QoQ
- Net income
- $161M
- +514.3% YoY · +447.0% QoQ
- Operating margin
- 76.0%
- EPS (diluted)
- $1.87
- +489.6% YoY · +428.1% QoQ
Source: XBRL data from the MeiraGTx Holdings plc (MGTX) Q2 2026 10-Q on SEC EDGAR. USD.
MeiraGTx Holdings plc Q2 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Quarterly net income $160.7M vs net loss $38.8M YoY
- Operating expenses $77.0M vs $48.5M YoY
- Cash, equivalents and restricted cash $145.4M at June 30, 2026
- Capital deployment: $25.0M bota-vec acquisition and $135.0M initial Oberland funding
- Funds expected to support operations into second half of 2028; additional capital required may remain necessary
Risk Factors
- New regulatory uncertainty: SEC proposed rescinding climate-disclosure rules in May 2026 after a 2024 adoption and litigation stay
- Most material financing update: $100.0 million April 2026 equity financing increased dilution exposure
- Legal risk: Cayman Islands courts may not recognize U.S. securities-law judgments against the company or its directors
- Near-term market risk: biopharmaceutical share-price volatility may trigger securities class-action litigation and substantial defense costs
- Financial risk: $28.2 million raised through 3,164,365 ATM shares during six months ended June 30, 2026
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other MeiraGTx Holdings plc quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.